Factor VIII Depleted Human Plasma

Product Description

Factor VIII Depleted Human Plasma
Catalog number: B2012697
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 5 mL
Molecular Weight or Concentration: N/A
Supplied as: Plasma
Applications: molecular tool for various biochemical applications
Storage: -20°C
Keywords: FVIII Deficient Plasma
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1: Mannucci PM. Hemophilia therapy: the future has begun Haematologica. 2020 Mar;105(3):545-553.
2: Takeyama M, Furukawa S, Onishi T, Noguchi-Sasaki M, Shima M, Nogami K. Heterogeneous coagulant potential of emicizumab in neonatal factor VIII-deficient plasma Pediatr Blood Cancer. 2022 Jul;69(7):e29731.
3: Qu J, Ma C, Xu XQ, Xiao M, Zhang J, Li D, Liu D, Konkle BA, Miao CH, Li L, Xiao W. Comparative glycosylation mapping of plasma-derived and recombinant human factor VIII PLoS One. 2020 May 22;15(5):e0233576.
4: Exner T, Rickard KA, Speers S. Factor VIII deficient plasma for laboratory tests prepared from normal plasma and a human antibody Haemostasis. 1977;6(3):157-62.
5: Takase T, Rotblat F, Goodall AH, Kernoff PB, Middleton S, Chand S, Denson KW, Austen DE, Tuddenham EG. Production of factor VIII deficient plasma by immunodepletion using three monoclonal antibodies Br J Haematol. 1987 Aug;66(4):497-502.
6: Hornsey VS, Waterston YG, Prowse CV. Artificial factor VIII deficient plasma: preparation using monoclonal antibodies and its use in one stage coagulation assays J Clin Pathol. 1988 May;41(5):562-7.
7: Loomans JI, Lock J, Peters M, Leebeek FW, Cnossen MH, Fijnvandraat K. [Haemophilia] Ned Tijdschr Geneeskd. 2014;158:A7357.
8: Noe DA, Bell WR, Ness PM, Levin J. Plasma clearance rates of coagulation factors VIII and IX in factor-deficient individuals Blood. 1986 Apr;67(4):969-72.
9: Nascimento B, Goodnough LT, Levy JH. Cryoprecipitate therapy Br J Anaesth. 2014 Dec;113(6):922-34.
10: Verbruggen B, Giles A, Samis J, Verbeek K, Mensink E, Novákovà I. The type of factor VIII deficient plasma used influences the performance of the Nijmegen modification of the Bethesda assay for factor VIII inhibitors Thromb Haemost. 2001 Dec;86(6):1435-9.

Products Related to Factor VIII Depleted Human Plasma can be found at Chemicals